Rishi Surana

6PUBLICATIONS
91CO-AUTHORS
Cancer diagnosisMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 11, 2026
Going beyond total skeletal muscle area at L3 (tSMA) to accurately assess pancreatic cancer cachexia.

|Sep 02, 2025
Open-Label, Phase II Trial of Extracellular Regulated Kinase Inhibition Alone and in Combination With Autophagy Inhibition in Patients With Metastatic Pancreatic Cancer.

Rishi Surana, Micaela Morgado, Ashwin Somasundaram

|Sep 16, 2024
Clinical and Genomic Features of Classical and Basal Transcriptional Subtypes in Pancreatic Cancer.

Harshabad Singh, Joanne Xiu, Kevin S Kapner

|Jul 11, 2024
Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the Tumor.

Paul E Oberstein, Andressa Dias Costa, Emily A Kawaler

|Jul 18, 2023
Oncogenic Drivers and Therapeutic Vulnerabilities in KRAS Wild-Type Pancreatic Cancer.

Harshabad Singh, Rachel B Keller, Kevin S Kapner

|Dec 23, 2022
Emerging Role of Targeted Therapy in Metastatic Pancreatic Adenocarcinoma.

Brandon M Huffman, Haley Ellis, Alexander C Jordan

Pageof 1

Frequent Collaborators

4 joint publications

Brandon M Huffman

4 joint publications

Douglas A Rubinson

4 joint publications

Andrew J Aguirre

4 joint publications

Harshabad Singh